Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernesto Moreno

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Journal of Molecular Recognition : JMR|April 1, 2020
Understanding the disrupting mechanism of the Tau aggregation motif "<sup>306</sup> VQIVYK<sup>311</sup> " by phenylthiazolyl-hydrazides inhibitorsElena Moreno-Castillo, Yoanna M Álvarez-Ginarte, Mario E Valdés-Tresanco, et al.
Molecules (Basel, Switzerland)|May 27, 2023
Selecting Nanobodies Specific for the Epidermal Growth Factor from a Synthetic Nanobody LibraryYunier Serrano-Rivero, Julieta Salazar-Uribe, Marcela Rubio-Carrasquilla, et al.
Memorias Do Instituto Oswaldo Cruz|April 13, 2013
Malaria entomological risk factors in relation to land cover in the Lower Caura River Basin, VenezuelaYasmin Rubio-Palis, Mariapia Bevilacqua, Domingo Alberto Medina, et al.
Tropical Animal Health and Production|August 4, 2010
Skin and coat traits in sheep in Brazil and their relation with heat toleranceConcepta McManus, Helder Louvandini, Rosilene Gugel, et al.
Molecular Immunology|April 4, 2006
Gangliosides, Ab1 and Ab2 antibodies I. Towards a molecular dissection of an idiotype-anti-idiotype systemAlejandro López-Requena, Cristina Mateo De Acosta, Ernesto Moreno, et al.
Molecular Immunology|February 11, 2011
Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibodyYuniel Fernández-Marrero, Tays Hernández, Lourdes Roque-Navarro, et al.
Molecular Immunology|April 20, 2006
Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case studyAlejandro López-Requena, Mabel Rodríguez, Cristina Mateo de Acosta, et al.
Cancer Research|July 9, 2009
Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformationAriel Talavera, Rosmarie Friemann, Silvia Gómez-Puerta, et al.
Frontiers in Immunology|November 9, 2020
A Direct Role for the CD1b Endogenous Spacer in the Recognition of a <i>Mycobacterium tuberculosis</i> Antigen by T-Cell ReceptorsFrank Camacho, Ernesto Moreno, Luis F Garcia-Alles, et al.
Molecules (Basel, Switzerland)|May 13, 2023
Design and Construction of a Synthetic Nanobody Library: Testing Its Potential with a Single Selection Round StrategyMaría Angélica Contreras, Yunier Serrano-Rivero, Alaín González-Pose, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Journal of Molecular Recognition : JMR|April 1, 2020
Understanding the disrupting mechanism of the Tau aggregation motif "<sup>306</sup> VQIVYK<sup>311</sup> " by phenylthiazolyl-hydrazides inhibitorsElena Moreno-Castillo, Yoanna M Álvarez-Ginarte, Mario E Valdés-Tresanco, et al.
Molecules (Basel, Switzerland)|May 27, 2023
Selecting Nanobodies Specific for the Epidermal Growth Factor from a Synthetic Nanobody LibraryYunier Serrano-Rivero, Julieta Salazar-Uribe, Marcela Rubio-Carrasquilla, et al.
Memorias Do Instituto Oswaldo Cruz|April 13, 2013
Malaria entomological risk factors in relation to land cover in the Lower Caura River Basin, VenezuelaYasmin Rubio-Palis, Mariapia Bevilacqua, Domingo Alberto Medina, et al.
Tropical Animal Health and Production|August 4, 2010
Skin and coat traits in sheep in Brazil and their relation with heat toleranceConcepta McManus, Helder Louvandini, Rosilene Gugel, et al.
Molecular Immunology|April 4, 2006
Gangliosides, Ab1 and Ab2 antibodies I. Towards a molecular dissection of an idiotype-anti-idiotype systemAlejandro López-Requena, Cristina Mateo De Acosta, Ernesto Moreno, et al.
Molecular Immunology|February 11, 2011
Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibodyYuniel Fernández-Marrero, Tays Hernández, Lourdes Roque-Navarro, et al.
Molecular Immunology|April 20, 2006
Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case studyAlejandro López-Requena, Mabel Rodríguez, Cristina Mateo de Acosta, et al.
Cancer Research|July 9, 2009
Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformationAriel Talavera, Rosmarie Friemann, Silvia Gómez-Puerta, et al.
Frontiers in Immunology|November 9, 2020
A Direct Role for the CD1b Endogenous Spacer in the Recognition of a <i>Mycobacterium tuberculosis</i> Antigen by T-Cell ReceptorsFrank Camacho, Ernesto Moreno, Luis F Garcia-Alles, et al.
Molecules (Basel, Switzerland)|May 13, 2023
Design and Construction of a Synthetic Nanobody Library: Testing Its Potential with a Single Selection Round StrategyMaría Angélica Contreras, Yunier Serrano-Rivero, Alaín González-Pose, et al.
Pageof 6